James Burns - Jan 1, 2022 Form 3 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Signature
/s/ William Cook, as Attorney in Fact for James Burns
Stock symbol
AGIO
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
3
Date filed
1/10/2022, 03:07 PM
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AGIO Common stock 8.26K Jan 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AGIO Restricted stock units Jan 1, 2022 Common stock 724 Direct F1, F2
holding AGIO Restricted stock units Jan 1, 2022 Common stock 5.25K Direct F2, F3
holding AGIO Restricted stock units Jan 1, 2022 Common stock 3.48K Direct F2, F4
holding AGIO Restricted stock units Jan 1, 2022 Common stock 8.75K Direct F2, F5
holding AGIO Restricted stock units Jan 1, 2022 Common stock 5.5K Direct F2, F6
holding AGIO Stock options (right to buy) Jan 1, 2022 Common stock 5.42K $43.77 Direct F7
holding AGIO Stock options (right to buy) Jan 1, 2022 Common stock 5.75K $50.40 Direct F8
holding AGIO Stock options (right to buy) Jan 1, 2022 Common stock 8.3K $77.70 Direct F9
holding AGIO Stock options (right to buy) Jan 1, 2022 Common stock 8.69K $58.86 Direct F10
holding AGIO Stock options (right to buy) Jan 1, 2022 Common stock 2.61K $51.51 Direct F11
holding AGIO Stock options (right to buy) Jan 1, 2022 Common stock 22K $56.68 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock units were granted on February 14, 2020. The shares underlying the restricted stock units will vest in full on February 14, 2022.
F4 The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.
F5 The restricted stock units were granted on December 23, 2020. The shares underlying the restricted stock units will vest in full on December 23, 2022.
F6 The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.
F7 This option was granted on April 4, 2016. The shares underlying this option are fully vested.
F8 This option was granted on February 21, 2017. The shares underlying this option are fully vested.
F9 This option was granted on February 16, 2018. The shares underlying this option vest as to 25% of the underlying shares on February 16, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F10 This option was granted on February 22, 2019. The shares underlying this option vest as to 25% of the underlying shares on February 22, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F11 This option was granted on February 14, 2020. The shares underlying this option vest as to 25% of the underlying shares on February 14, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F12 This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.